Arbutus Biopharma (ABUS) came out with a quarterly loss of $0.07 per share versus the Zacks Consensus Estimate of a loss of $0.08. This compares to loss of $0.12 per share a year ago. These ...
WARMINSTER, Pa., March 27, 2025 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS) (“Arbutus” or the “Company”), a clinical-stage ...
Arbutus Biopharma and Genevant Sciences are broadening the scope of their patent infringement claims against Moderna with five new international lawsuits. It’s the latest development in a bitter ...
WARMINSTER, Pa., March 27, 2025 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS) ("Arbutus” or the "Company”), a clinical-stage biopharmaceutical company focused on infectious disease, ...
Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection in the United States. Its HBV product pipeline consists of ...
BASEL, Switzerland and VANCOUVER, B.C. and WARMINSTER, Pa., March 03, 2025 (GLOBE NEWSWIRE) -- Genevant Sciences, a leading nucleic acid delivery company with world-class platforms and a robust ...
Tattoos may be linked to an increased risk of cancer, according to a new study. Researchers at the University of South Denmark and the University of Helsinki have found tattoo ink may increase the ...
Your next tattoo might be riskier than currently assumed, recent research suggests. Scientists found evidence of a potential link between tattoo ink and a higher risk of certain cancers.
U.S. officials in court filings say that tattoos worn by Venezuelan migrants are ample reason for their removal to a notorious Salvadoran prison. Family members and advocates say immigration ...
Research has shown that tattoo ink does not just remain where it is injected. Particles from the ink can migrate to the lymph nodes, where they accumulate. People often put a lot of thought into ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results